PharmiWeb.com - Global Pharma News & Resources
10-May-2023

EUROAPI’s Board of Directors Proposes Géraldine Leveau as Director

PARIS--(BUSINESS WIRE)--Regulatory News:


The Board of Directors of EUROAPI (Paris:EAPI) proposes the ratification of the appointment by co-optation of a new director, Géraldine Leveau, as of May 10, 2023, replacing Jean-Christophe Dantonel, who resigned from his directorship. Her appointment will be proposed to ratification at the Annual General Meeting approving the financial statements as of December 31, 2023.

Géraldine Leveau has been appointed Deputy Secretary General for Investment in 2021 by the French Prime Minister. She is co-piloting France 2030, a €54 billion plan to promote innovation and reindustrialization. Previously, she was Advisor to the French Minister of Higher Education, Research and Innovation, and Head of the Office of Innovation Ecosystems at the Ministry of Economy and Finance. A French citizen, Géraldine Leveau holds a master's degree in political administration from Université Paris 1 Panthéon-Sorbonne.

“Géraldine Leveau has gained extensive experience in innovation and in particular a strong knowledge of the start-up ecosystem. Her recognized reindustrialization skills will be an important asset to our Board," said Viviane Monges, Chair of the Board of Directors of EUROAPI. "The entire Board of Directors would like to thank Jean-Christophe Dantonel for his valuable contribution to the Board's work.”

About EUROAPI

EUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities.

Taking action for health by enabling access to essential therapies inspires our 3,450 people every day. With strong research and development capabilities and six manufacturing sites all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris (Ticker: EAPI – ISIN: FR0014008VX5). Find out more at www.euroapi.com and follow us on LinkedIn

Forward-Looking Statements

Certain information contained in this press release is forward looking and not historical data. These forward-looking statements are based on opinions, projections and current assumptions including, but not limited to, assumptions concerning the Group’s current and future strategy, financial and non-financial future results and the environment in which the Group operates, as well as events, operations, future services or product development and potential. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Forward looking statements and information do not constitute guarantees of future performances, and are subject to known or unknown risks, uncertainties and other factors, a large number of which are difficult to predict and generally outside the control of the Group, which could cause actual results, performances or achievements, or the results of the sector or other events, to differ materially from those described or suggested by these forward-looking statements. These risks and uncertainties include those that are indicated and detailed in Chapter 3 “Risk factors” of the Universal Registration Document approved by the French Financial Markets Authority (Autorité des marchés financiers, AMF) on April 14, 2023, under number R.23-009 and the Amendment to Universal Registration Document approved by the AMF on April 25, 2023 under number R.23-015. These forward-looking statements are given only as of the date of this press release and the Group expressly declines any obligation or commitment to publish updates or corrections of the forward-looking statements included in this press release in order to reflect any change affecting the forecasts or events, conditions or circumstances on which these forward-looking statements are based.


Contacts

Media Relations:
Laurence Bollack
Mob.: +33 (0)6 81 86 80 19
mr@euroapi.com

Investor Relations:
Sophie Palliez-Capian
Mob.: +33 (0)6 87 89 33 51
ir@euroapi.com

Editor Details

  • Company:
    • Businesswire
Last Updated: 10-May-2023